PHOENIX LABS NY
GenericsPHOENIX LABS NY is a generic drug manufacturer focused on Respiratory, Dermatology.
PHOENIX LABS NY's Key Drugs
PHOENIX LABS NY's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PHOENIX LABS NY's Recent FDA Approvals
New NDA/BLA approvals for PHOENIX LABS NY over the last two years — novel drugs only, excluding generics and label supplements.
PHOENIX LABS NY's Therapeutic Areas
PHOENIX LABS NY's approved drugs and pipeline span 2 therapeutic areas, led by Respiratory and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PHOENIX LABS NY's Top Competitors
PHOENIX LABS NY's closest competitors by therapeutic-area and drug-target overlap include Bayer, APOTHECON, and PHARMACIA AND UPJOHN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PHOENIX LABS NY Pipeline Snapshot
Active clinical trials for PHOENIX LABS NY across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Respiratory pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1974-09-09
- Latest
- 1975-12-18
- Applications
- 6